caspase-3 inhibitors (Chemical Diversity Research Institute)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namecaspase-3 inhibitors (Chemical Diversity Research Institute)
Drug Alias NameCDL-001-0011
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCaspase-3 inhibitors
TargetsCaspase-3
Therapy Area/IndicationsAlzheimer DiseaseParkinson DiseaseLiver Diseases +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAlzheimer DiseaseParkinson DiseaseLiver Diseases +[4

Other Information

ATC CodeN/A
Related LinksN/A